Value of a quality assessment program in optimizing cryopreservation of peripheral blood mononuclear cells in a multicenter study

Clinical and Vaccine Immunology

Volumn 20, Issue 4, 2013, Pages 590-595

  Aziz, Najib ^a,b   Margolick, Joseph B ^c,d   Detels, Roger ^a,b   Rinaldo, Charles R ^e   Phair, John ^f   Jamieson, Beth D ^a   Butch, Anthony W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; PHYTOHEMAGGLUTININ;

ARTICLE; CD3+ CD4+ T LYMPHOCYTE; CD3+ CD8+ T LYMPHOCYTE; CD3+ T LYMPHOCYTE; CELL PROLIFERATION; CELL VIABILITY; CLINICAL PROTOCOL; CONTROLLED STUDY; CRYOPRESERVATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITY CONTROL; T LYMPHOCYTE; THAWING;

ANTIGENS, CD; CELL PROLIFERATION; CRYOPRESERVATION; CYTOLOGICAL TECHNIQUES; HUMANS; LEUKOCYTES, MONONUCLEAR; TIME FACTORS;

EID: 84876497725     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00693-12     Document Type: Article

References (19)

1. Chattopadhyay PK, Douek DC, Gange SJ, Chadwick KR, Hellerstein M, Margolick JB. 2006. Longitudinal assessment of de novo T cell production in relation to HIV-associated T cell homeostasis failure. AIDS Res. Hum. Retroviruses 6:501-507.
2. Rinaldo CR, Jr, Beltz LA, Huang XL, Gupta P, Fan Z, Torpey DJ III. 1995. Anti-HIV type 1 cytotoxic T lymphocyte effector activity and disease progression in the first 8 years of HIV type 1 infection of homosexual men. AIDS Res. Hum. Retroviruses 11:481-489.
3. Chmiel JS, Detels R, Kaslow RA, Van Raden M, Kingsley LA, Brookmeyer R. 1987. Factors associated with prevalent human immunodeficiency virus (HIV) infection in the Multicenter AIDS Cohort Study. Am. J. Epidemiol. 126:568-577.
4. Kaslow RA, Ostrow DG, Detels R, Phair JP, Polk BF, Rinaldo CR, Jr. 1987. The Multicenter AIDS Cohort Study: Rationale, organization and selected characteristics of the participants. Am. J. Epidemiol. 126:310-318.
5. Kleeberger CA, Lyles RH, Margolick JB, Rinaldo CR, Phair JP, Giorgi JV. 1999. Viability and recovery of peripheral blood mononuclear cells cryopreserved for up to 12 years in a multicenter study. Clin. Diagn. Lab. Immunol. 6:14-19.
6. Bull M, Lee D, Stucky J, Chiu YL, Rubin A, Horton H, McElrath MJ. 2007. Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials. J. Immunol. Methods 322:57-69.
7. Hultin LE, Chow M, Jamieson BD, O'Gorman MR, Menendez FA, Borowski L, Denny TN, Margolick JB. 2010. Comparison of interlaboratory variation in absolute T-cell counts by single-platform and optimized dual-platform methods. Cytometry B Clin. Cytom. 78:194-200.
8. Resino S, Abad ML, Navarro J, Bellón JM, Sánchez- Ramón S, Angeles Muñoz-Fernández M. 2003. Stimulated proliferative responses in vertically HIV-infected children on HAART correlate with clinical and immunological markers. Clin. Exp. Immunol. 131:130-137.
9. Baust JM, Van Buskirk R, Baust JG. 1998. Cryopreservation outcome is enhanced by intracellular-type medium and inhibition of apoptosis. Cryobiology 37:410-411.
10. Riccio EKP, Neves I, Jr, Banic DM, Corte-Real S, das Gracas Alcerim M, Morgado M, Daniel-Ribeiro CT, Ferreira-da-Cruz MDF. 2002. Cryopreservation of peripheral blood mononuclear cells does not significantly affect the levels of spontaneous apoptosis after 24-h culture. Cryobiology 45:127-134.
11. Reimann KA, Chernoff M, Wilkening CL, Nickerson CE, Landay AL. 2000. Preservation of lymphocyte immunophenotype and proliferative responses in cryopreserved peripheral blood mononuclear cells from human immunodeficiency virus type 1-infected donors: Implications for multicenter clinical trials. Clin. Diagn. Lab. Immunol. 7:352-359.
12. Weinberg A, Betensky RA, Zhang L, Graham R. 1998. Effect of shipment, storage, anticoagulant, and cell separation on lymphocyte proliferation assays for human immunodeficiency virus-infected patients. Clin. Diagn. Lab. Immunol. 5:804-807.
13. Weinberg A, Zhang L, Brown D, Erice A, Polsky B, Hirsch MS, Owens S, Lamb K. 2000. Viability and functional activity of cryopreserved mononuclear cells. Clin. Diagn. Lab. Immunol. 7:714-716.
14. Weinberg A, Song LY, Wilkening C, Sevin A, Blais B, Louzao R, Stein D, Defechereux P, Durand D, Riedel E, Raftery N, Jesser R, Brown B, Keller MF, Dickover R, McFarland E, Fenton T, Pediatric ACTG Cryopreservation Working Group. 2009. Optimization and limitations of use of cryopreserved peripheral blood mononuclear cells for functional and phenotypic T-cell characterization. Clin. Vaccine Immunol. 16:1176-1186.
15. Costantini A, Mancini S, Giuliodoro S, Butini L, Regnery CM, Silvestri G, Montroni M. 2003. Effects of cryopreservation on lymphocyte immunophenotype and function. J. Immunol. Methods 278:145-155.
16. Owen RE, Sinclair E, Emu B, Heitman JW, Hirschkorn DF, Epling CL, Tan QX, Custer B, Harris JM, Jacobson MA, McCune JM, Martin JN, Hecht FM, Deeks SG, Norris PJ. 2007. Loss of T cell responses following long-term cryopreservation. J. Immunol. Methods 326:93-115.
17. Seale AC, de Jong BC, Zaidi I, Duvall M, Whittle W, Rowland-Jones S, Jaye A. 2008. Effects of cryopreservation on CD4? CD25? T cell of HIV-1 infected individuals. J. Clin. Lab. Anal. 22:153-158.
18. Smith JG, Joseph HR, Green T, Field JA, Wooters M, Kaufhold RM, Antonello J, Caulfield MJ. 2007. Establishing acceptance criteria for cellmedicated-immunity assays using frozen peripheral blood mononuclear cells stored under optimal and suboptimal conditions. Clin. Vaccine Immunol. 14:527-537.
19. Weinberg A, Louzao R, Mussi-Pinhata MM, Cruz MLS, Pinto JA, Huff MF, de Castro AC, Sucupira MC, Denny TN. 2007. Quality assurance program for peripheral blood mononuclear cell cryopreservation. Clin. Vaccine Immunol. 14:1242-1244.